Oncology Institute Inc
NASDAQ:TOI
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.285
2.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TOI stock under the Base Case scenario is 3.38 USD. Compared to the current market price of 0.31 USD, Oncology Institute Inc is Undervalued by 91%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Oncology Institute Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TOI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Oncology Institute Inc
Balance Sheet Decomposition
Oncology Institute Inc
Current Assets | 116.2m |
Cash & Short-Term Investments | 46.4m |
Receivables | 54.4m |
Other Current Assets | 15.5m |
Non-Current Assets | 63.4m |
PP&E | 39.2m |
Intangibles | 23.6m |
Other Non-Current Assets | 582k |
Current Liabilities | 35.1m |
Accounts Payable | 15.8m |
Accrued Liabilities | 13.1m |
Other Current Liabilities | 6.2m |
Non-Current Liabilities | 115.3m |
Long-Term Debt | 90m |
Other Non-Current Liabilities | 25.3m |
Earnings Waterfall
Oncology Institute Inc
Revenue
|
361.1m
USD
|
Cost of Revenue
|
-305.7m
USD
|
Gross Profit
|
55.4m
USD
|
Operating Expenses
|
-118.9m
USD
|
Operating Income
|
-63.6m
USD
|
Other Expenses
|
5m
USD
|
Net Income
|
-58.5m
USD
|
Free Cash Flow Analysis
Oncology Institute Inc
USD | |
Free Cash Flow | USD |
In Q2 2024, The Oncology Institute reported a revenue increase of 22.9% year-over-year, reaching $98.6 million, largely driven by their new California pharmacy. However, margins were pressured due to rising DIR fees, leading to a gross profit of $13 million. The company updated its guidance for full-year gross profit to a range of $62 million to $69 million and adjusted EBITDA to between negative $21 million and negative $28 million. Encouragingly, new capitation contracts are expected to contribute over $41 million in revenue, enhancing profitability potential as they go live in Q3.
What is Earnings Call?
TOI Profitability Score
Profitability Due Diligence
Oncology Institute Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Oncology Institute Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
TOI Solvency Score
Solvency Due Diligence
Oncology Institute Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Score
Oncology Institute Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TOI Price Targets Summary
Oncology Institute Inc
Dividends
Current shareholder yield for TOI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
TOI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.
Contact
IPO
Employees
Officers
The intrinsic value of one TOI stock under the Base Case scenario is 3.38 USD.
Compared to the current market price of 0.31 USD, Oncology Institute Inc is Undervalued by 91%.